FibroGen Inc.

NASDAQ: FGEN · Real-Time Price · USD
9.49
0.01 (0.11%)
At close: Aug 15, 2025, 3:59 PM
9.44
-0.58%
After-hours: Aug 15, 2025, 07:24 PM EDT

FibroGen Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
50.48M 113.69M 155.7M 171.22M
Short-Term Investments
n/a 121.9M 266.31M 233.97M
Long-Term Investments
n/a 5.29M 9.41M 171.62M
Other Long-Term Assets
18.02M 5.31M 7.35M 7.99M
Receivables
28.98M 41.05M 16.3M 25.4M
Inventory
3.15M 41.56M 40.44M 31.02M
Other Current Assets
111.99M 6.71M 4.35M 5.07M
Total Current Assets
196.51M 331.56M 492.83M 474.06M
Property-Plant & Equipment
n/a 81.37M 100.5M 120.15M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
18.02M 91.97M 117.26M 299.76M
Total Assets
214.53M 423.53M 610.09M 773.82M
Account Payables
5.06M 17.96M 30.76M 26.1M
Deferred Revenue
27.29M 12.74M 13.13M 15.86M
Short-Term Debt
n/a 40K 10.33M 10.96M
Other Current Liabilities
100.95M 152.58M 4.18M 140.72M
Total Current Liabilities
133.31M 217.67M 273.56M 225.5M
Long-Term Debt
90.1M 89.7M 16.92M 17.61M
Other Long-Term Liabilities
59.97M 54.17M 55.64M 26.02M
Total Long-Term Liabilities
264.85M 368.06M 338M 319.21M
Total Liabilities
398.16M 585.73M 611.57M 544.71M
Total Debt
73.09M 170.46M 89.89M 117.35M
Common Stock
1.01M 988K 942K 929K
Retained Earnings
-1.89B -1.84B -1.56B -1.26B
Comprehensive Income
-5.73M -6.88M -5.72M -4.16M
Shareholders Equity
-225.6M -204.17M -21.45M 209.15M
Total Investments
n/a 127.19M 275.72M 405.59M